3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
8
Carcinoma, Non-Small-Cell Lung
7
Pancreatic Neoplasms
6
Colorectal Neoplasms
6
Stomach Neoplasms
5
Carcinoma, Renal Cell
5
Uterine Cervical Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Rectal Neoplasms
4
Neoplasms
4
Nasopharyngeal Carcinoma
4
Triple Negative Breast Neoplasms
3
Neoplasm Metastasis
3
Esophageal Squamous Cell Carcinoma
3
Endometrial Neoplasms
3
Skin Neoplasms
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Lung Neoplasms
2
Glioblastoma
2
Advanced Solid Tumors
2
von Hippel-Lindau Disease
1
Thyroid cancer, follicular
1
Thyroid cancer, Hurthle cell
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Stomach Adenocarcinoma
1
Solid Tumors
1
Solid Tumor, Adult
1
Solid Tumor
1
Interventions
pembrolizumab
25
Cisplatin
20
Carboplatin
14
Paclitaxel
11
Radiotherapy
9
Radiotherapy, Intensity-Modulated
8
Docetaxel
8
Cetuximab
8
Nivolumab
7
cemiplimab
5
Radiation
5
durvalumab
4
atezolizumab
3
Taxes
3
Surveys and Questionnaires
3
Fluorouracil
3
Drug Therapy
3
Cyclophosphamide
3
Blood Specimen Collection
3
toripalimab
2
olaparib
2
fludarabine
2
avelumab
2
alpha-2'-deoxythioguanosine
2
aldesleukin
2
Surgical Procedures, Operative
2
Standard of Care
2
Pemetrexed
2
Magnetic Resonance Spectroscopy
2
vistusertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
spartalizumab
×
1 year
×
Clear all
No trials found.